In particular, the continuous treatment effectiveness and safety of both amphetamine and methylphenidate have been demonstrated in controlled drug trials with durations of several years.
This work ranges from trials of new therapies and preventative treatments, to studies seeking to understand the genetic and biological basis of addictive behaviour.
Unless randomized control trials and meta-analyses really pluck at your heart strings, most articles in medical journals likely won't leave you misty-eyed.